Normoammonemic encephalopathy: solely valproate induced or multiple mechanisms?. (10th March 2014)

• Record Type: Journal Article
• Authors: Budhdeo, Sanjay; Marquette, Malcolm; Singh, Deepwant; Rajagopal, Vivek
• Is Part Of: BMJ case reports. Volume 2014
• Publication Date: 2014-03-10
• Subjects: Medicine -- Case studies -- Periodicals; 610.5
• DOI: 10.1136/bcr-2013-201928
• Languages: English
• ISSNs: 1757-790X

Abstract

Abstract : A 77-year-old woman presented with subacute onset progressive confusion, aggression, auditory hallucinations and delusions. In the preceding months, the patient had a number of admissions with transient unilateral hemiparesis with facial droop, and had been started on valproate for presumed hemiplegic migraine. Valproate was withdrawn soon after admission and her cognitive abilities have gradually improved over 3 months of follow-up. Valproate levels taken prior to withdrawal were subtherapeutic and the patient was normoammonaemic. EEG undertaken during inpatient stay showed changes consistent with encephalopathy, and low titre N -methyl-d -aspartate (NMDA) receptor antibodies were present in this patient. The possible aetiologies of valproate-induced encephalopathy and NMDA receptor-associated encephalitis present a diagnostic dilemma. We present a putative combinatorial hypothesis to explain this patient's symptoms.